Skip to content
Search

Latest Stories

Antisemitic comment: GPhC ordered to reconsider FtP decision on London pharmacist

The High Court today (23 June) quashed a decision by the General Pharmaceutical Council (GPhC) in relation to the alleged antisemitic comments made by London pharmacist Nazim Ali.

In an appeal filed by the Professional Standards Authority (PSA), the court found that the Fitness to Practice (FtP) committee of the GPhC erred in taking into account of the intention and character of Ali when the allegation was, however, simply that the words used by him were offensive and antisemitic.


“[The FtP committee] wrongly took account of Mr Ali’s intention when assessing whether his language was objectively antisemitic. It wrongly took account of his character when assessing whether his language was objectively antisemitic. And it erroneously failed to assess whether the remarks, considered cumulatively, were objectively antisemitic, as opposed to whether each remark in isolation was anti-Semitic,” Justice Johnson, of the Queen's Bench division of the court, said in the judgment.

The case pertains to a rally led by Ali on 18 June 2017 to demonstrate support for Palestinian rights, in which he made the comments in question. Currently the managing partner of Chelsea Pharmacy in London, he was not acting as a pharmacist when the rally took place.

After an allegation was made against him that he had thereby said things that were antisemitic and offensive, FtP committee in November 2020 ruled that his comments were offensive but not antisemitic. The committee concluded that Ali’s use of the words, which he admitted were grossly offensive, amounted to serious misconduct and that his fitness to practise was thereby impaired, and issued him with a warning.

The PSA appealed to the High Court against the finding, saying the committee had erred in its approach and incorrectly taken into account his intention and character, rather than taking a purely objective approach.

The GPhC did not contest the appeal, agreeing to the contention by the PSA.

“We will make sure the learnings from this case and the High Court judgment are shared across the organisation and our committees,” Duncan Rudkin, chief executive of the GPHC, said, adding that the further FtP hearing for Ali will be scheduled at the earliest opportunity.

Contesting the appeal, Ali, who also performs as a stand-up comedian, noted that a warning would be appropriate even if his language is found to be antisemitic as that was the sanction suggested by the GPhC in its opening submissions at FtP hearing.

Justice Johnson said he is “in principle, sympathetic to the suggestion”, but noted that the case does engage “significant questions of public confidence.”

“It is vitally important that all sections of the community are able to place trust and confidence in pharmacists,” he wrote in the judgment. “That is vividly illustrated by the current pandemic, and the need that all communities are able to have confidence in advice given by pharmacists and other professionals about the risks and benefits of vaccination. Public confidence is an important consideration when considering sanction.”

The judge decided to remit the case to the FtP committee for reconsideration, saying that the committee is better placed to make an assessment as to the appropriate sanction to be imposed.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less